RxDoctor Payments Data

Jeremy Hubbard

Family · Covington, TNNPI 1033638499

Payments from drug & device makers

$1,493in general payments, 2019–2025

Across 77 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$468
  • Lilly USA, LLC$332
  • Mylan Specialty L.p.$171
  • Axsome Therapeutics, Inc.$158
  • AstraZeneca$107
  • Merck$48
  • plus $210 from 8 others

What the payments were for

  • Food & beverage$1,493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,493 in reported general payments places this provider in the 70th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$132
Medicare patients
23
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$112,729
JardianceEmpagliflozin89$102,016
MounjaroTirzepatide64$76,799
EliquisApixaban70$62,096
FarxigaDapagliflozin Propanediol51$61,447
JanuviaSitagliptin Phosphate36$40,544
TrulicityDulaglutide34$38,115
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$25,803
XareltoRivaroxaban24$22,192
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$19,183
LinzessLinaclotide11$12,958
Trijardy XrEmpaglifloz/Linaglip/Metformin12$7,249
Lantus SolostarInsulin Glargine,hum.Rec.Anlog73$6,908
Repatha SureclickEvolocumab12$6,624
TrintellixVortioxetine Hydrobromide12$5,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$332$114,91498 claims
Novo NordiskOzempic$468$112,72995 claims
Boehringer IngelheimJardiance, Trijardy Xr$35$109,265101 claims
AstraZenecaFarxiga, Breztri Aerosphere$107$80,63075 claims
PfizerEliquis$13$62,09670 claims
MerckJanuvia$48$40,54436 claims
GSKTrelegy Ellipta$15$25,80330 claims
AbbVieLinzess$12$12,95811 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$45$5,80912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,706 family providers in Tennessee.

Other family in Covington

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →